← Leaderboards
Dena E Cohen
Regenerative Medical Solutions, Inc.
$1,449,698
Attributed
$1,449,698
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $915.1K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,449,698 · 3
By mechanism
R44$915,136 · 1
R41$274,984 · 1
R43$259,578 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Islets Of Langerhans”
- Xiaoxiao Wan · Washington University$3,667,189
- Pei-Hsun Wu · Johns Hopkins University$2,847,704
- Yue Wang · Florida State University$2,782,476
- Alphonsus Ng · University Of Utah$2,758,753
- Lucienne Chatenoud · Ut Southwestern Medical Center$1,755,880
- David Lorberbaum · Children'S Hosp Of Philadelphia$1,573,885
Research focus
Islets Of LangerhansPancreas TransplantationHumanized MouseIsletMedicalOrgan DonorDiabetes MellitusGraft FunctionInduced Pluripotent Stem CellIn VivoIslets Of Langerhans TransplantationDiabetic MouseDifferentiation ProtocolDoseBeta CellCellsGlycemic ControlBlood GlucoseBlood Glucose RegulationImmunosuppressionInsulinCell TransplantationDiabetic PatientPharmaceutical Preparations
Grant awards (3)
Development of a safer stem cell-based diabetes therapy via suicide gene-mediated ablation of proliferative cells$915,136
R44 · FY2025 · DK · contact PI
Evaluation of a beta cell replacement therapy combined product that avoids the need for immunosuppression via localized induction of immune tolerance$274,984
R41 · FY2022 · DK · contact PI
Development of a safer stem cell-based diabetes therapy via suicide gene-mediated ablation of proliferative cells$259,578
R43 · FY2022 · DK · contact PI